Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial

被引:0
作者
Broeckelmann, Paul J. [1 ]
Buehnen, Ina [1 ]
Herhaus, Peter [2 ]
Meissner, Julia [3 ]
Trautmann-Grill, Karolin [4 ]
Mueller, Horst [1 ]
Fuchs, Michael [1 ]
von Tresckow, Bastian [5 ]
Borchmann, Peter [1 ]
Engert, Andreas [1 ]
Behringer, Karolin [1 ]
机构
[1] Univ Hosp Cologne, Dept Internal Med, German Hodgkin Study Grp GHSG, Cologne, Germany
[2] Tech Univ Munich, Sch Med, Clin & Policlin Internal Med 3, Klinikum Rechts Isar, Munich, Germany
[3] Univ Hosp Heidelberg, Med 5, Heidelberg, Germany
[4] Univ Hosp Carl Gustav Carus, Med Clin 1, Dresden, Germany
[5] West German Canc Ctr Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany
关键词
D O I
10.1182/blood-2023-189250
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
[41]   Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy [J].
Tracy L. Rose ;
David D. Chism ;
Ajjai S. Alva ;
Allison M. Deal ;
Susan J. Maygarden ;
Young E. Whang ;
Jordan Kardos ;
Anthony Drier ;
Ethan Basch ;
Paul A. Godley ;
Mary W. Dunn ;
William Y. Kim ;
Matthew I. Milowsky .
British Journal of Cancer, 2018, 119 :801-807
[42]   A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC) [J].
Palumbo, Raffaella ;
Bernardo, Antonio ;
Strada, Maria Rosa ;
Poggi, Guido ;
Delmonte, Angelo ;
Teragni, Cristina ;
Frascaroli, Mara ;
Bernardo, Giovanni .
ANNALS OF ONCOLOGY, 2006, 17 :75-75
[43]   Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma [J].
Piperno-Neumann, Sophie ;
Diallo, Alhassane ;
Etienne-Grimaldi, Marie-Christine ;
Bidard, Francois-Clement ;
Rodrigues, Manuel ;
Plancher, Corine ;
Mariani, Pascale ;
Cassoux, Nathalie ;
Decaudin, Didier ;
Asselain, Bernard ;
Servois, Vincent .
ONCOLOGIST, 2016, 21 (03) :281-282
[44]   Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma: Interim follow-up of a multicenter phase II trial [J].
Hainsworth, JD .
SEMINARS IN ONCOLOGY, 2002, 29 (01) :25-29
[45]   Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial [J].
Kahl, Brad S. ;
Burke, John M. ;
van der Jagt, Richard ;
Chang, Julie ;
Wood, Peter ;
Hawkins, Tim ;
MacDonald, David ;
Trotman, Judith ;
Simpson, David ;
Kolibaba, Kathryn S. ;
Issa, Samar ;
Hallman, Doreen ;
Chen, Ling ;
Flinn, Ian W. .
BLOOD, 2017, 130
[46]   PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma [J].
Buckley, Hannah L. ;
Collinson, Fiona J. ;
Ainsworth, Gemma ;
Poad, Heather ;
Flanagan, Louise ;
Katona, Eszter ;
Howard, Helen C. ;
Murden, Geraldine ;
Banks, Rosamonde E. ;
Brown, Joanne ;
Velikova, Galina ;
Waddell, Tom ;
Fife, Kate ;
Nathan, Paul D. ;
Larkin, James ;
Powles, Thomas ;
Brown, Sarah R. ;
Vasudev, Naveen S. .
BMC CANCER, 2019, 19 (01)
[47]   PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma [J].
Hannah L. Buckley ;
Fiona J. Collinson ;
Gemma Ainsworth ;
Heather Poad ;
Louise Flanagan ;
Eszter Katona ;
Helen C. Howard ;
Geraldine Murden ;
Rosamonde E. Banks ;
Joanne Brown ;
Galina Velikova ;
Tom Waddell ;
Kate Fife ;
Paul D. Nathan ;
James Larkin ;
Thomas Powles ;
Sarah R. Brown ;
Naveen S. Vasudev .
BMC Cancer, 19
[48]   Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer - a phase II trial [J].
Palumbo, R. ;
Bernardo, A. ;
Strada, M. ;
Teragni, C. ;
Poggi, G. ;
Frascaroli, M. ;
Amatu, A. ;
Palumbo, I. ;
Bernardo, G. .
EJC SUPPLEMENTS, 2008, 6 (07) :177-177
[49]   Phase II trial of oxaliplatin plus capecitabine as first-line treatment in patients with advanced gastric cancer (AGC) [J].
Palumbo, R. ;
Bernardo, A. ;
Strada, M. R. ;
Poggi, G. ;
Teragni, C. ;
Delmonte, A. ;
Frascaroli, M. ;
Jedrychowska, I ;
Canto, A. M. ;
Bernardo, G. .
ANNALS OF ONCOLOGY, 2006, 17 :XI51-XI52
[50]   A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer [J].
Yardley, Denise A. ;
Burris, Howard. A., III ;
Simons, Lisa ;
Spigel, David R. ;
Greco, E. Anthony ;
Barton, John H. ;
Shipley, Dianna ;
Drosick, David ;
Hainsworth, John D. .
CLINICAL BREAST CANCER, 2008, 8 (05) :425-431